The high-risk thin-cap fibroatheroma: A new kid on the block

Circulation: Cardiovascular Interventions

Volumn 2, Issue 6, 2009, Pages 500-502

  Moreno, Pedro R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Editorials; Plaque; Vulnerable

Indexed keywords

CD163 ANTIGEN; HEME OXYGENASE; HIGH DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ACUTE CORONARY SYNDROME; ATHERECTOMY; ATHEROSCLEROTIC PLAQUE; CELL INFILTRATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; EDITORIAL; ERYTHROCYTE MEMBRANE; HEART CATHETER; HEART CATHETERIZATION; HEART INFARCTION; HYPERGLYCEMIA; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MACROPHAGE; NEAR INFRARED SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OXIDATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; THROMBOSIS;

CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FIBROSIS; HUMANS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; RUPTURE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77953666104     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.109.922146     Document Type: Editorial

References (20)

1. Fuster V. Assessing and Modifying the Vulnerable Atherosclerotic Plaque. American Heart Association Monograph Series. Armonk, NY: Futura Publishing Company, Inc; 2002:1-377.
2. Waksman R, Serruys PW. Handbook of the Vulnerable Plaque. Boca Raton, FL: Taylor and Francis; 2004:1- 418.
3. Virmani R, Narula J, Leon MB, Willerson JT. The Vulnerable AtheroscleroticPlaque. Strategies for Diagnosis and Management. Malden MA: Blackwell Futura; 2007:1-375.
4. Lindsey JB, House JA, Kennedy KF, Marso SP. Diabetes duration is associated with increased thin-cap fibroatheroma detected by IntravascularUltrasound with Virtual Histology. Circ Cardiovasc Interv. 2009;2:543-548.
5. Moreno PR, Bernardi VH, Lopez-Cuellar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes.Circulation. 1996;94:3090 -3097.
6. Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J, Finn AV, Virmani R. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol. 2001;16:285-292.
7. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, Naruse H, Ishii J, Hishida H, Wong ND, Virmani R, Kondo T, Ozaki Y, Narula J. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54:49 -57.
8. Waxman S, Dixon SR, L'Allier P, Moses JW, Petersen JL, Cutlip D, Tardif JC, Nesto RW, Muller JE, Hendricks MJ, Sum ST, Gardner CM, Goldstein JA, Stone GW, Krucoff MW. In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:858-868.
9. Garcia-Garcia HM, Gonzalo N, Regar E, Serruys PW. Virtual histology and optical coherence tomography: from research to a broad clinical application. Heart. 2009;95:1362-1374.
10. Rodriguez-Granillo GA, Garcia-Garcia HM, McFadden EP, Valgimigli M, Aoki J, de Feyter P, Serruys PW. In vivo intravascular ultrasoundderived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol. 2005;46:2038 -2042.
11. Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol. 2004;44:2293-2300.
12. Moreno PR, Murcia AM, Palacios IF, Leon MN, Bernardi VH, Fuster V, Fallon JT. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation.2000;102:2180 -2184.
13. Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol. 2004;24:1266 -1271.
14. Kalet-Litman S, Moreno PR, Levy AP. The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque. Atherosclerosis. In press.
15. Levy AP, Moreno PR. Intraplaque hemorrhage. Curr Mol Med. 2006;6:479-488.
16. Moreno PR, Sanz J, Fuster V. Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. J Am Coll Cardiol. 2009;53:2315-2323.
17. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000; 20:1262-1275.
18. Stone GW. Results from landmark PROSPECT trial demonstrate the ability of volcano's VH(R) IVUS imaging to identify plaques most likely to cause heart attacks. Available at: http://www.reuters.com/article/ pressRelease/ idUS181026+24-Sep-2009+PRN20090924. Accessed November 8, 2009.
19. Braunwald E. Noninvasive detection of vulnerable coronary plaques: locking the barn door before the horse is stolen. J Am Coll Cardiol.2009;54:58 -59.
20. Ramcharitar S, Gonzalo N, van Geuns RJ, Garcia-Garcia HM, Wykrzykowska JJ, Ligthart JM, Regar E, Serruys PW. First case of stenting of a vulnerable plaque in the SECRITT I trial-the dawn of a new era? Nat Rev Cardiol. 2009;6:374 -378.